Forte Biosciences Inc. (NASDAQ: FBRX) stock closed at 0.498 per share at the end of the most recent trading day (a 5.06% change compared to the prior day closing price) with a volume of 43.23K shares and market capitalization of 18.09M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 9 people. Forte Biosciences Inc. CEO is Paul A. Wagner.

The one-year performance of Forte Biosciences Inc. stock is -52.59%, while year-to-date (YTD) performance is -50.2%. FBRX stock has a five-year performance of -99.74%. Its 52-week range is between 0.38 and 1.2899, which gives FBRX stock a 52-week price range ratio of 12.97%

Forte Biosciences Inc. currently has a PE ratio of -1.30, a price-to-book (PB) ratio of 0.50, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -28.95%, a ROC of -28.54% and a ROE of -30.93%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Forte Biosciences Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Forte Biosciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Forte Biosciences Inc. is Moderate Buy (2), with a target price of $3.5, which is +602.81% compared to the current price. The earnings rating for Forte Biosciences Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Forte Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Forte Biosciences Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 19.67, ATR14 : 0.04, CCI20 : 100.06, Chaikin Money Flow : 0.24, MACD : -0.02, Money Flow Index : 65.59, ROC : 15.57, RSI : 52.60, STOCH (14,3) : 90.83, STOCH RSI : 1.00, UO : 57.62, Williams %R : -9.17), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Forte Biosciences Inc. in the last 12-months were: Hubert C. Chen (Option Excercise at a value of $0), Paul A. Wagner (Buy at a value of $107 892), Paul A. Wagner (Option Excercise at a value of $0), Riley Antony (Sold 0 shares of value $0 )